KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Depreciation & Amortization (CF) (2016 - 2026)

Staar Surgical (STAA) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $2.0 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 15.49% year-over-year to $2.0 million, compared with a TTM value of $8.3 million through Jan 2026, up 20.72%, and an annual FY2026 reading of $8.3 million, up 20.72% over the prior year.
  • Depreciation & Amortization (CF) was $2.0 million for Q1 2026 at Staar Surgical, roughly flat from $2.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $2.4 million in Q4 2024 and bottomed at $994000.0 in Q2 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $1.6 million, with a median of $1.4 million recorded in 2022.
  • The sharpest move saw Depreciation & Amortization (CF) surged 88.92% in 2025, then fell 15.49% in 2026.
  • Year by year, Depreciation & Amortization (CF) stood at $1.4 million in 2022, then dropped by 0.87% to $1.4 million in 2023, then soared by 73.61% to $2.4 million in 2024, then decreased by 15.79% to $2.0 million in 2025, then grew by 0.35% to $2.0 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for STAA at $2.0 million in Q1 2026, $2.0 million in Q3 2025, and $2.0 million in Q2 2025.